Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-002934

Chief Accounting Officer sold 310 shares at $0.64 ($198)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-04 Sale : show line 1 in the form −310 $0.64 $198 97,190 D
Open-market sales · 310 sh · avg $0.64 · $198
Loading xslF345X05/ownership.xml…